newsfilter
← Latest News
Business Wire·

Natera Shares Real-World Analyses and Data at ASN Kidney Week 2026, Highlighting the Critical Need for Genetic Testing with Renasight™

Analyses drawn from a large real-world database of patients underscore how genetic testing can support better care in chronic kidney disease (CKD) Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and